
๐๐ก๐๐ง๐๐ฅ๐๐ซ ๐๐๐ซ๐ค ๐๐ ๐ ๐๐๐
13K posts

๐๐ก๐๐ง๐๐ฅ๐๐ซ ๐๐๐ซ๐ค ๐๐ ๐ ๐๐๐
@CParkMD
๐Oncologist|๐งฌCancer Research|President Ky @ASCO|Advisory Dean/Professor @UofL Med School |Faculty @ASCO @NCCN | My Podcast ๐ https://t.co/Of3PVK4RFS









Join us this weekend for the Fellows & Trainee Advisory Panel from 4โ5 PM after the MOASC Annual Oncology Leadership &Research Summit! It's an amazing opportunity to network with our speakers and get the inside scoop on how to build a successful career! Register: bit.ly/4bkzDP4 @montypal @minasedrakmd @DrJZell @PatelOncology @UCLAHealthJCCC @UCIrvineHealth @UCSDCancer @cityofhope @uscnorris @CSCancerCenter @PDZOnc @kor_shah @thehemeoncdoc @SalvadorjcMD @AlkassisSamer @MarkChangDO @RWinayak @omgitsyuliaz @MoldenhauerMR



Few key studies that we touched on with @PGrivasMDPhD from #GU26 โ CREST/POTOMAC (update) โ EV304/KeynoteB15 (new SoC) โ LITESPARK-011 & 022 โ CAPItello-281 #OncTwitter #gusm #MedX @OncUpdates @OncoAlert




UNITE study data @ASCO #GU26 with @JasonBrownMDPhD In aUC treated with EVP, early ctDNA reduction (โฅ50% or โฅ90%) was strongly associated with improved PFS and OS! However, baseline ctDNA levels were not predictive. Early dynamics may guide monitoring @urotoday @Uromigos



































